Drug Profile
TV 46017
Alternative Names: 46017; TEV-46017; TV-46017Latest Information Update: 28 Apr 2018
Price :
$50
*
At a glance
- Originator Teva Pharmaceutical Industries
- Class Bronchodilators
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Chronic obstructive pulmonary disease
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Chronic-obstructive-pulmonary-disease in Australia (Inhalation)
- 28 Apr 2018 No recent reports of development identified for phase-I development in Chronic-obstructive-pulmonary-disease in New Zealand (Inhalation)
- 28 Apr 2018 No recent reports of development identified for phase-I development in Chronic-obstructive-pulmonary-disease in USA (Inhalation)